误传
膀胱过度活动
医学
家庭医学
替代医学
政治学
病理
法学
作者
Alexandra L. Tabakin,Sharon Choi,Arshia Sandozi,Kelli Aibel,Michael Weintraub,Harvey A. Winkler,Dara F. Shalom,Justina Tam,Wai Lee
标识
DOI:10.1097/spv.0000000000001431
摘要
Importance Millions of people rely on social media platforms, including TikTok, for health-related information. TikTok has not yet been evaluated as an information source for overactive bladder (OAB) third-line therapies. Objectives Our aim was to assess TikTok videos on third-line therapies for OAB for misinformation and quality. Study Design In this cross-sectional analysis, we abstracted the top 50 TikTok videos for keywords: “Axonics,” “sacral neuromodulation,” “Interstim,” “PTNS,” “posterior tibial nerve stimulation,” and “bladder Botox.” Videos were scored for quality by 3 independent reviewers using the Medical Quality Video Evaluation Tool (MQ-VET). Two reviewers determined if videos contained misinformation. Results Of 300 videos screened, 119 videos were included. Twenty-four (21%) were created by medical professionals (MPs). Medical professional videos were more frequently shared (5 vs 1, P < 0.01) but had similar views, likes, comments, and length. Although MP videos had significantly higher MQ-VET scores (43 vs 27, P < 0.01), there was no difference in the rate of misinformation between MP and non-MP videos (21% vs 18%). Twenty-two videos (18.4%) contained misinformation, which were 3 times longer (50.5 vs 15 seconds, P < 0.01) and had higher MQ-VET scores (34.5 vs 27, P = 0.03) than those without misinformation. Common themes of misinformation pertained to therapy indication, mechanism of action, and patient limitations after undergoing therapy. Conclusions Many TikTok videos on OAB third-line therapies contain misinformation. Most of these videos were not of high quality and created by the public. Medical professionals should be aware of misinformation permeating TikTok, given its large audience, and aim to promote or offer educational material of better accuracy and quality.
科研通智能强力驱动
Strongly Powered by AbleSci AI